Minerva Biotechnologies

Exploring the Space between Stem Cells and Cancers

  • Stems Cells & Reagents
  • Functionalized Nanoparticles
  • Cancer Therapeutics

Show me more

Latest Products

News

  • Dr. Bamdad gives presentation at International Stem Cell Conference

    Dr. Bamdad gives presentation at International Stem Cell Conference

    Presented in Stockholm, Sweden June 25, 2015 at the Annual Meeting of the International Society of Stem Cell Researchers A PRIMITIVE GROWTH FACTOR IS SUFFICIENT TO INDUCE STABLE NAÏVE STATE HUMAN PLURIPOTENCY VIA A LIF- AND FGF-INDEPENDENT PATHWAY; REPROGRAMMING IN THIS NOVEL GROWTH FACTOR CONFERS SUPERIOR DIFFERENTIATION   Scientists have generated human stem cells that […]

    Read More

  • Minerva Awarded Grant by the National Institutes of Health

    Minerva Awarded Grant by the National Institutes of Health

    Minerva Biotechnologies has been awarded a grant by the NIAID division of the National Institutes of Health. The study that is funded involves testing in animals, Minerva’s growth factor that in vitro stimulate the growth of human bone marrow cells that are needed to make blood cells. If successful these growth factors could become drugs […]

    Read More

  • stem cell major breakthrough

    STEM CELL MAJOR BREAKTHROUGH PLoS ONE

    Waltham, MA. Minerva Biotechnologies, a leading cancer and stem cell development company today announced a major breakthrough in human stem cell research. Minerva scientists converted established human stem cells to the elusive “naïve” state and maintained them there indefinitely simply by culturing the cells in the dimeric form of a natural, but newly discovered human […]

    Read More